Amedisys Inc (AMED)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 2,348,320 | 2,236,380 | 2,223,200 | 2,214,110 | 2,071,520 |
| Total current assets | US$ in thousands | 632,083 | 496,935 | 388,961 | 356,684 | 361,984 |
| Total current liabilities | US$ in thousands | 514,392 | 473,721 | 355,529 | 374,282 | 456,337 |
| Working capital turnover | 19.95 | 96.34 | 66.50 | — | — |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $2,348,320K ÷ ($632,083K – $514,392K)
= 19.95
Working capital turnover is a financial ratio that measures how efficiently a company utilizes its working capital to generate sales revenue. In the case of Amedisys Inc, the working capital turnover ratio for the financial years ending on December 31, 2022 and December 31, 2023, stood at 66.50 and 96.34, respectively. These values indicate that the company efficiently utilized its working capital to generate sales during these years. However, there was a significant decrease in the working capital turnover ratio to 19.95 for the year ending on December 31, 2024. This decline may suggest a decrease in the efficiency of working capital management compared to the previous years. It is important for Amedisys Inc to monitor and improve its working capital turnover to ensure optimal utilization of resources for revenue generation.
Peer comparison
Dec 31, 2024